The effea of tubocurarine and gallamine pretreatments on suxamethonium relaxation was measured in 81 patients. The blocking effect of a constant infusion of suxamethonium (0.58 mg/sec) on the recorded thumb adduction in response to supramaximal ulnar nerve stimulation was reproducible in 18 control subjects: infusion time for 50% block was 37.7 (±SEM 1.02) sec. Tubocurarine 3 mg and 6 mg increased the infusion time required to produce 50 % block by 33.4 and 54.8 % respectively. Gallamine had a similar effect. Chnical conditions for endotracheal intubation were evaluated on a blind basis. Both drugs produced impairment of chnical conditions for intubation after suxamethonium 60 mg infusion. However, when pretreatment by tubocurarine 3 mg was followed by suxamethonium infusion at 1 mg/sec the time course of neuromuscular blockade was identical to that of the controls. There were no fasciculations with this dosage and conditions for endotracheal intubation were excellent.
. However, all these investigations attempted to assess the effects of tubocurarine (d.t.c.) or gallamine (G) pretreatment on the degree of block from a single dose of Sch by following its time course of onset and recovery. There is an inherent problem in attempting to assess differences in intensity of neuromuscular block when the dose of Sch produces 100% block of the phenomenon being observed,-thumb adduction in response to stimulation of the ulnar nerve.
As an alternative, we measured the infusion time and thus the total dose of Sch, administered at a constant rate, required to produce equivalent neuromuscular block following incremental doses of d.t.c. or G in an otherwise standardized induction sequence, thus producing dose-response curves. Concurrently, we evaluated the effect of d.tx. and G pretreatment on chnical conditions for intubation resulting from the infusion of the total dose of 60 mg Sch (1 mg/kg) using a protocol which prevented observer bias.
When we found that pretreatment with d.t.c. or G did in fact necessitate greater total doses of Sch, we studied a more rapid infusion of Sch following d.t.c. This was done in order to discover whether a larger dose of Sch reintroduced the phenomena which one was trying to avoid with d.t.c. pretreatment.
METHODS
The subjects were 81 fasting, gynaecological patients, 18-45 years of age, and weighing in the range 62.2-65.8 kg (115-145 lb.) (table I) , physical status I, with normal body habitus, for whom endotracheal nitrous oxide and relaxant anaesthesia was considered an appropriate anaesthetic technique. Patients were excluded if they had received any medications other than secobarbitone 100 mg on the previous night. Premedication was secobarbitone 100 mg, morphine 10 mg, atropine 0.5 mg, 45-90 min before induction. The first 27 patients were assigned to three groups to receive 0, 3, or 6 mg of tubocurarine chloride (E. R. Squibb) in a Latin square design: the sequence of assigned pretreatments was 0, 3, 6, 3, 6, 0, 6, 0, 3, etc. milligrams d.t.c . The next 36 patients received gallamine (Flaxedil; Davis and Geek, American Cyanamid Co.) 0, 10, 20, 30 mg in the same way.
The assigned drug pretreatment was administered in a total volume of 2 ml. Thus the dose was unknown to the anaesthetist, who administered the anaesthetic and who also assessed the patient with respect to fasciculations, muscle relaxation, and conditions for endotracheal intubation.
Before induction of anaesthesia an 18-gauge plastic venous cannula was placed in a vein in the upper left forearm. Dextrose 5 % in 0.45 % saline was administered through a "T connector" (Abbott) which allowed drug infusions to be made directly into the venous cannula. A Grass strain gauge, FT-03, modified in a fashion similar to that described by Walts, Lebowitz and Dillon (1968) , was placed in the left hand for monitoring of the thumb twitch in response to ulnar nerve stimulation.
Exactly 120 sec after injection of the pretreatment, the patients were anaesthetized with thiopentone 350 mg, administered over 30 sec into the rapidly running stream of the intravenous infusion. Anaesthesia was continued with nitrous oxide in oxygen (7:3 litre/min) with assisted ventilation. Needle electrodes were placed over the ulnar nerve at the wrist and elbow and a supramaximal stimulus (1 Hz, 0.1 msec duration) was delivered from an American Electronic Laboratory stimulator, Model 104A. Thumb adduction was recorded continually by a Grass polygraph. At 240 sec the supramaximal stimulus was discontinued for 30 sec. At 270 sec the stimulus was resumed, and at 300 sec administration of suxamethonium (Anectine, Burroughs-Wellcome) was begun from a Harvard pump (Model 1100) delivering Sch 0.58 mg/sec from a 10-ml disposable syringe directly into the venous cannula being flushed by the rapidly running intravenous infusion. The total dose of Sch 60 mg was delivered in 1 min 44 sec.
The anaesthetist graded fasciculations as follows: None Minimal-fine movements of face and neck only. Moderate-fine movements of face, neck, and extremities. Marked-gross movements of face, neck, and extremities. On completion of the total infusion of Sch 60 mg, the trachea was intubated. The anaesthetist assessed the degree of jaw relaxation as follows: good, fair, or poor.
Bucking on the endotracheal tube was evaluated as: none, minimal, moderate, or marked.
Recording of thumb twitch was continued until 50% recovery of twitch height occurred. The results were tabulated as the required time, thus implying the infused dose of Sch required for several specific degrees of neuromuscular block: 10, 30, 40, 70, 90, 100%.
Differences were analysed for statistical significance by Student's t test or the Chi-square test, as appropriate. hibited significantly, in a dose-related manner, the relaxation produced by suxamethonium (Sch). Pretreatment with d.t.c. or G increased the total dose of Sch, infused at 0.58 mg/sec, required to produce a specified depression of twitch height (table II, figs. 1 and 2). Pretreatment prevented fasciculations; however, even with tubocurarine 3 mg or gallamine 10 mg, doses which did not prevent fasciculations completely, there was significant impairment of the clinical conditions for endotracheal intubation; jaw relaxation was not always adequate and there was coughing after placement of the endotracheal tube (table III) . Larger doses of tubocurarine (6 mg) or gallamine (20 or 30 mg), which prevented fasciculations completely, resulted in even poorer conditions for endotracheal intubation, more coughing on the endotracheal tube and, following gallamine, poorer jaw relaxation. Pretreatment with gallamine 20 or 30 mg produced more impairment of Sch jaw relaxation than d.tx. 6 mg (table III) .
RESULTS

Pretreatment with tubocurarine or gallamine in-
Non-depolarizing drugs can produce selective inhibition of Sch fasciculations. When d.t.c. 3 mg was followed by Sch 1 mg/sec for 104 sec, the time course of neuromuscular block was identical to that resulting from a smaller dose of Sch in the control subjects. No fasciculations were seen and the conditions for endotracheal intubation were excellent (fig. 4, tables II and III) .
Surprisingly, the addition of gallamine 10 mg to Most recent studies agree on these points. Nevertheless, Miller and Way (1971b) found that gallamine 20 mg or d.t.c. 3 mg preceding Sch 1 mg/kg given as a bolus did not alter significantly the onset or magnitude of thumb twitch block. However, d.t.c. shortened the recovery from Sch. Freund and Rubin (1972) found, using a similar technique, a larger effect of d.t.c. 3 mg on the recovery time from Sch 0.7 mg/kg. Walts and Dillon (1969) observed that Sch 4 mg produced 60% block whereas following d.Lc. 3 mg it was almost devoid of effect. Thus it appears that the ease with which d.t.c. or gallamine inhibition of Sch block can be demonstrated depends upon the dose of Sch used. During recovery from Sch block, and also during slow infusion, the situation becomes comparable with that seen when small doses of Sch are used.
Conflicting conclusions can result also from differences in methodology. Cullen (1971) , who evaluated clinical conditions for endotracheal intubation and the time to total abolition of thumb twitch (visual monitoring) in response to ulnar nerve stimulation by a Blockade Monitor, reported that d.t.c. 3 mg or gallamine 20 mg interfered significantly with conditions for endotracheal intubation and delayed the onset of Sch block. Miller and Way (1971b) reported that these doses of d.t.c. or gallamine did not inhibit significantly the neuromuscular block produced by Sch 1 mg/kg. They observed in five patients that three repeated identical doses of Sch (1 mg/kg) given to the same patient at 10-and 20-min intervals produced identical responses in neuromuscular block. In another group of 20 patients, administration of d.t.c. 3 mg or gallamine 20 mg, 3 min before the third dose of Sch, did not alter the time to development of complete neuromuscular block. However, these authors did not evaluate clinical conditions for intubation.
Our results show that significant differences in the degree of muscle relaxation may be present in patients who appear to exhibit complete block as determined by the customary methods of neuromuscular monitoring. All our patients had complete (and thus a similar degree of) block of neuromuscular response as monitored by thumb adduction following infusion of Sch 60 mg, following 0, 3, or 6 mg d.Lc, or 10,20, or 30 mg of gallamine. Only those who received d.tc. or gallamine coughed moderately or markedly on endotracheal intubation. This disparity between the conditions for endotracheal intubation and block of the twitch response has also been demonstrated clearly by Coppage, Wolfson and Siker (1972) . These authors compared conditions for intubation and twitch suppression produced by Sch 0.6 mg/kg with that observed when d.tc. 3 mg was followed by 0.6, 0.8, 1.0, and 1.2 mg/kg of Sch in 50 patients. Conditions for intubation were poor following d.t.c. in those patients who received 0.6,0.8, and 1.0 mg/kg of Sch. However, twitch suppression and its duration were significantly different from the controls only in the patients who received the smallest dose of Sch (0.6 mg/kg). Our results show an additional discrepancy between relaxation of thumb adduction in response to nerve stimulation and coughing in response to endotracheal intubation. We can offer no explanation fcr the exaggeration of the discrepancy between the Sch relaxation of the hand muscles and the jaw and respiratory muscles produced by the combination of d.tc. and G. This observation emphasizes further the need for extensive and simultaneous monitoring of the effects of pretreatment with non-depolarizing relaxants on the Sch block if erroneous conclusions are to be avoided.
Our alternative method of evaluating muscle relaxant interactions offers advantages. Measurement of suxamethonium block during a thiopentone induction sequence follows the usual clinical practice and eliminates several conflicting factors. Administration of Sch at a fixed time early in the anaesthetic minimized variations produced by changes in arterial PcOi and pH. Other anaesthetic drugs with known or uncertain interactions with relaxants were avoided. Tachyphylaxis to repeated doses of suxamethonium was eliminated. Relaxants were used only as they were indicated by anaesthetic or surgical criteria. Limited variation in the population studied, use of uniform premedication, and avoidance of all other medications presumably accounts for the smaller variation in response to Sch than has been reported previously (Katz and Ryan, 1969) . The technique readily produced data in the form of dose-response curves showing that even small doses of d.tx. or gallamine clearly inhibit Sch relaxation so that a larger dose of Sch is needed to produce the same degree of relaxation.
Therefore, if d.t.c. or gallamine is used to minimize a specific undesirable side effect of Sch, it becomes necessary to evaluate that side effect with the now increased dose of Sch required to produce equivalent neuromuscular block. We found that even with a 75% greater rate of Sch infusion, d.t.c. 3 mg pretreatment abolished fasciculations without impairment of relaxation of hand, jaw, and respiratory muscles These findings confirm Cullen's (1971) report of the need to increase the dose of Sch from 1 to 1.5 mg/kg in order to achieve good relaxation after d.t.c. 3 mg or gallamine 20 mg. Our results also confirm those of Freund and Rubin (1972) , who measured the duration of total block and the time to 50 and 90% recovery, finding that when d.t.c. 3 mg preceded Sch, a dose 70% greater than that without pretreatment was required to produce the same degree of block without the presence of fasciculations. By contrast, it is not en-tirely dear from the studies of increases in intragastric pressure (Miller and Way, 1971a) or increases in intraocular pressure (Miller, Way and Hickey, 1968) associated with Sch if an equivalent blocking dose of Sch following d.t.c. will still be free of the undesired side effect.
La Cour (1970) pointed out that the advantages of tubocurarine pretreatment in blocking the Schinduced increase in intragastric pressure may be negated occasionally in the patient who coughs on intubation because of poor relaxation from Sch. Since an increase in intragastric pressure is related to fasciculations, d.Lc. or gallamine pretreatment seems logical if adequate Sch is given to avoid coughing on intubation. In the prevention of myalgias, Dottori, Lof and Ygge (1965) presented evidence that d.t.c. 3 mg pretreatment necessitated the use of 25% more Sch infusion to achieve comparable relaxation. However, the d.t.c. eliminated post-Sch myalgias even when the 25% larger total dose of Sch was administered. We have not measured the incidence of myalgias.
Attempts to control Sch hyperkalaemia by d.t.c. or gallamine can be criticized from presently available information. Although the previous administration of d.t.c. may reduce Sch hyperkalaemia (Cooperman, 1970) , cardiac arrest has been reported in patients receiving preteatment with d.t.c. 6 mg (Smith, 1971) .
A recommendation that d.LC. be given to block the side effects of Sch is made with the accompanying warning that 70-75% more Sch is required for the same degree of block. Previous recommendations as to the size of this increase in dosage of Sch have varied from 25 to 70% (Dottori, Lof and Ygge, 1965; Freund and Rubin, 1972 
SUMAKIO
Se midio en 81 pacientes el efecto de los pretratamientos de la galamina y tubocurarina sobre la relajacibn del suxametonio. El efecto de bloqueo de una infusi6n constante de suxametonio (0,58 mg/seg) sobre la aducci6n pulgar registrada en respuesta al esdmulo del nervio ulnar supramaximo fue reproducible en 18 casos controlados: el tiempo de infusi6n para una obstrucci6n del 50% fue de 37,7 (± SEM 1,02) segundos. La tubocurarina de 3 mg y 6 mg increment6 el tiempo de infusi6n requerido para producir 50% de bloqueo por 33,4 y 54,8% respectivamente. La gnlarriing tuvo un efecto similar. Se evaluaron a ciegas las condiciones cllnicas para la entubaci6n endotraqueal. Ambas drogas produjeron empeoramiento de las condiciones dinicas para la entubaci6n despues de 60 mg de una infusion de suxametonio. Sin embargo, cuando al pretxatamiento con tubocurarina de 3 mg siguio la infusi6n de suxametonio a 1 m/seg el curso del tiempo del bloqueo neuromuscular fue identico al de los controles. No hubo fasciculaciones con esta dosis y las condiciones para la entubaci6n endotraqueal fueron excelentes.
